Aperio Group, LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$1,792,000
+6.2%
41,461
+3.8%
0.02%
+5.9%
Q2 2015$1,687,000
+48.5%
39,930
+36.3%
0.02%
+30.8%
Q1 2015$1,136,000
+32.6%
29,297
+15.1%
0.01%
+18.2%
Q4 2014$857,000
+72.8%
25,449
+79.6%
0.01%
+57.1%
Q3 2014$496,000
+17.5%
14,172
+10.4%
0.01%
+16.7%
Q2 2014$422,000
-23.7%
12,837
-14.4%
0.01%
-25.0%
Q1 2014$553,000
+114.3%
14,997
+122.8%
0.01%
+100.0%
Q4 2013$258,0006,7310.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 241,186$9,353,00020.89%
Sensato Investors LLC 672,513$26,080,0005.62%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,781,889$107,882,0003.77%
Sloane Robinson LLP 57,500$2,230,0003.35%
Grandeur Peak Global Advisors, LLC 344,518$13,360,0002.83%
THOMAS WHITE INTERNATIONAL LTD 474,694$18,409,0002.58%
Granite Point Capital Management, L.P. 180,000$6,980,0002.56%
COMGEST GLOBAL INVESTORS S.A.S. 2,058,180$79,816,0002.49%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 234,071$9,077,0002.47%
DECADE CAPITAL MANAGEMENT LLC 389,735$15,114,0001.87%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders